Freeman RS, Burch RL, Crowder RJ, Lomb DJ, Schoell MC, Straub JA, Xie L (2004). "NGF deprivation-induced gene expression: after ten years, where do we stand?". Progress in Brain Research. Progress in Brain Research 146: 111–26. ISBN978-0-444-51472-1. PMID14699960. doi:10.1016/S0079-6123(03)46008-1.
Lee R, Kermani P, Teng KK, Hempstead BL (Nov 2001). "Regulation of cell survival by secreted proneurotrophins". Science294 (5548): 1945–8. PMID11729324. doi:10.1126/science.1065057.
Otten, U.; Goedert, M.; Baumann, J. B.; Girard, J. (1981-07-27). "Stimulation of the pituitary-adrenocortical axis and induction of tyrosine hydroxylase by nerve growth factor are not dependent on mouse submaxillary gland isorenin". Brain Research217 (1): 207–211. ISSN0006-8993. PMID6114784. doi:10.1016/0006-8993(81)90202-x.
Lipov, Eugene; Kelzenberg, Briana; Rothfeld, Courtney; Abdi, Salahadin (2012-12-01). "Modulation of NGF by cortisol and the Stellate Ganglion Block - is this the missing link between memory consolidation and PTSD?". Medical Hypotheses79 (6): 750–753. ISSN1532-2777. PMID22998954. doi:10.1016/j.mehy.2012.08.019.
Kaplan DR, Martin-Zanca D, Parada LF (Mar 1991). "Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF". Nature350 (6314): 158–60. PMID1706478. doi:10.1038/350158a0.
Tuszynski MH, Blesch A (2004). "Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease". Progress in Brain Research146: 441–9. PMID14699979. doi:10.1016/s0079-6123(03)46028-7.
Freund V, Frossard N (2004). "Expression of nerve growth factor in the airways and its possible role in asthma". Progress in Brain Research146: 335–46. PMID14712791. doi:10.1016/S0079-6123(03)46021-4.
Althaus HH (2004). "Remyelination in multiple sclerosis: a new role for neurotrophins?". Progress in Brain Research146: 415–32. PMID14699977. doi:10.1016/S0079-6123(03)46026-3.
Villoslada P, Genain CP (2004). "Role of nerve growth factor and other trophic factors in brain inflammation". Progress in Brain Research146: 403–14. PMID14699976. doi:10.1016/S0079-6123(03)46025-1.
Hempstead BL (Feb 2006). "Dissecting the diverse actions of pro- and mature neurotrophins". Current Alzheimer Research3 (1): 19–24. PMID16472198. doi:10.2174/156720506775697061.
Allen SJ, Dawbarn D (Feb 2006). "Clinical relevance of the neurotrophins and their receptors". Clinical Science110 (2): 175–91. PMID16411894. doi:10.1042/CS20050161.
Parikh V, Evans DR, Khan MM, Mahadik SP (Apr 2003). "Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome". Schizophrenia Research60 (2–3): 117–23. PMID12591576. doi:10.1016/S0920-9964(02)00434-6.
Lukoyanov NV, Pereira PA, Paula-Barbosa MM, Cadete-Leite A (Jan 2003). "Nerve growth factor improves spatial learning and restores hippocampal cholinergic fibers in rats withdrawn from chronic treatment with ethanol". Experimental Brain Research148 (1): 88–94. PMID12478399. doi:10.1007/s00221-002-1290-7.
Riikonen R, Vanhala R (Mar 1999). "Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome". Developmental Medicine and Child Neurology41 (3): 148–52. PMID10210246. doi:10.1111/j.1469-8749.1999.tb00573.x.
Gorbachevskaya N, Bashina V, Gratchev V, Iznak A (Dec 2001). "Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study". Brain & Development. 23 Suppl 1: S90–3. PMID11738849. doi:10.1016/S0387-7604(01)00349-7.
Barbosa IG, Huguet RB, Neves FS, Reis HJ, Bauer ME, Janka Z, Palotás A, Teixeira AL (Apr 2011). "Impaired nerve growth factor homeostasis in patients with bipolar disorder". The World Journal of Biological Psychiatry12 (3): 228–32. PMID20923384. doi:10.3109/15622975.2010.518629.
Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A, Ghenev PI, Aloe L (2004). "Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?". Progress in Brain Research146: 279–89. PMID14699970. doi:10.1016/S0079-6123(03)46018-4.
Chaldakov GN, Fiore M, Tonchev AB, Dimitrov D, Pancheva R, Rancic G, Aloe L (2007). "Homo obesus: a metabotrophin-deficient species. Pharmacology and nutrition insight". Current Pharmaceutical Design13 (21): 2176–9. PMID17627549. doi:10.2174/138161207781039616.
Manni L, Nikolova V, Vyagova D, Chaldakov GN, Aloe L (Jun 2005). "Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes". International Journal of Cardiology102 (1): 169–71. PMID15939120. doi:10.1016/j.ijcard.2004.10.041.
Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, Jacobsen C, Kliemannel M, Schwarz E, Willnow TE, Hempstead BL, Petersen CM (Feb 2004). "Sortilin is essential for proNGF-induced neuronal cell death". Nature427 (6977): 843–8. PMID14985763. doi:10.1038/nature02319.
Wiesmann C, Ultsch MH, Bass SH, de Vos AM (Sep 1999). "Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor". Nature401 (6749): 184–8. PMID10490030. doi:10.1038/43705.
Freeman RS, Burch RL, Crowder RJ, Lomb DJ, Schoell MC, Straub JA, Xie L (2004). "NGF deprivation-induced gene expression: after ten years, where do we stand?". Progress in Brain Research. Progress in Brain Research 146: 111–26. ISBN978-0-444-51472-1. PMID14699960. doi:10.1016/S0079-6123(03)46008-1.
Lee R, Kermani P, Teng KK, Hempstead BL (Nov 2001). "Regulation of cell survival by secreted proneurotrophins". Science294 (5548): 1945–8. PMID11729324. doi:10.1126/science.1065057.
Otten, U.; Goedert, M.; Baumann, J. B.; Girard, J. (1981-07-27). "Stimulation of the pituitary-adrenocortical axis and induction of tyrosine hydroxylase by nerve growth factor are not dependent on mouse submaxillary gland isorenin". Brain Research217 (1): 207–211. ISSN0006-8993. PMID6114784. doi:10.1016/0006-8993(81)90202-x.
Lipov, Eugene; Kelzenberg, Briana; Rothfeld, Courtney; Abdi, Salahadin (2012-12-01). "Modulation of NGF by cortisol and the Stellate Ganglion Block - is this the missing link between memory consolidation and PTSD?". Medical Hypotheses79 (6): 750–753. ISSN1532-2777. PMID22998954. doi:10.1016/j.mehy.2012.08.019.
Kaplan DR, Martin-Zanca D, Parada LF (Mar 1991). "Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF". Nature350 (6314): 158–60. PMID1706478. doi:10.1038/350158a0.
Crowder RJ, Freeman RS (Apr 1998). "Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons". The Journal of Neuroscience18 (8): 2933–43. PMID9526010.
Tuszynski MH, Blesch A (2004). "Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease". Progress in Brain Research146: 441–9. PMID14699979. doi:10.1016/s0079-6123(03)46028-7.
Freund V, Frossard N (2004). "Expression of nerve growth factor in the airways and its possible role in asthma". Progress in Brain Research146: 335–46. PMID14712791. doi:10.1016/S0079-6123(03)46021-4.
Althaus HH (2004). "Remyelination in multiple sclerosis: a new role for neurotrophins?". Progress in Brain Research146: 415–32. PMID14699977. doi:10.1016/S0079-6123(03)46026-3.
Villoslada P, Genain CP (2004). "Role of nerve growth factor and other trophic factors in brain inflammation". Progress in Brain Research146: 403–14. PMID14699976. doi:10.1016/S0079-6123(03)46025-1.
Chaldakov GN, Tonchev AB, Aloe L (2009). "NGF and BDNF: from nerves to adipose tissue, from neurokines to metabokines". Rivista Di Psichiatria44 (2): 79–87. PMID20066808.
Counts SE, Mufson EJ (Apr 2005). "The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease". Journal of Neuropathology and Experimental Neurology64 (4): 263–72. PMID15835262.
Hempstead BL (Feb 2006). "Dissecting the diverse actions of pro- and mature neurotrophins". Current Alzheimer Research3 (1): 19–24. PMID16472198. doi:10.2174/156720506775697061.
Allen SJ, Dawbarn D (Feb 2006). "Clinical relevance of the neurotrophins and their receptors". Clinical Science110 (2): 175–91. PMID16411894. doi:10.1042/CS20050161.
Parikh V, Evans DR, Khan MM, Mahadik SP (Apr 2003). "Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome". Schizophrenia Research60 (2–3): 117–23. PMID12591576. doi:10.1016/S0920-9964(02)00434-6.
Lukoyanov NV, Pereira PA, Paula-Barbosa MM, Cadete-Leite A (Jan 2003). "Nerve growth factor improves spatial learning and restores hippocampal cholinergic fibers in rats withdrawn from chronic treatment with ethanol". Experimental Brain Research148 (1): 88–94. PMID12478399. doi:10.1007/s00221-002-1290-7.
Riikonen R, Vanhala R (Mar 1999). "Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome". Developmental Medicine and Child Neurology41 (3): 148–52. PMID10210246. doi:10.1111/j.1469-8749.1999.tb00573.x.
Gorbachevskaya N, Bashina V, Gratchev V, Iznak A (Dec 2001). "Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study". Brain & Development. 23 Suppl 1: S90–3. PMID11738849. doi:10.1016/S0387-7604(01)00349-7.
Barbosa IG, Huguet RB, Neves FS, Reis HJ, Bauer ME, Janka Z, Palotás A, Teixeira AL (Apr 2011). "Impaired nerve growth factor homeostasis in patients with bipolar disorder". The World Journal of Biological Psychiatry12 (3): 228–32. PMID20923384. doi:10.3109/15622975.2010.518629.
Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A, Ghenev PI, Aloe L (2004). "Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?". Progress in Brain Research146: 279–89. PMID14699970. doi:10.1016/S0079-6123(03)46018-4.
Chaldakov GN, Fiore M, Tonchev AB, Dimitrov D, Pancheva R, Rancic G, Aloe L (2007). "Homo obesus: a metabotrophin-deficient species. Pharmacology and nutrition insight". Current Pharmaceutical Design13 (21): 2176–9. PMID17627549. doi:10.2174/138161207781039616.
Manni L, Nikolova V, Vyagova D, Chaldakov GN, Aloe L (Jun 2005). "Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes". International Journal of Cardiology102 (1): 169–71. PMID15939120. doi:10.1016/j.ijcard.2004.10.041.
Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, Jacobsen C, Kliemannel M, Schwarz E, Willnow TE, Hempstead BL, Petersen CM (Feb 2004). "Sortilin is essential for proNGF-induced neuronal cell death". Nature427 (6977): 843–8. PMID14985763. doi:10.1038/nature02319.
Wiesmann C, Ultsch MH, Bass SH, de Vos AM (Sep 1999). "Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor". Nature401 (6749): 184–8. PMID10490030. doi:10.1038/43705.
Otten, U.; Goedert, M.; Baumann, J. B.; Girard, J. (1981-07-27). "Stimulation of the pituitary-adrenocortical axis and induction of tyrosine hydroxylase by nerve growth factor are not dependent on mouse submaxillary gland isorenin". Brain Research217 (1): 207–211. ISSN0006-8993. PMID6114784. doi:10.1016/0006-8993(81)90202-x.
Lipov, Eugene; Kelzenberg, Briana; Rothfeld, Courtney; Abdi, Salahadin (2012-12-01). "Modulation of NGF by cortisol and the Stellate Ganglion Block - is this the missing link between memory consolidation and PTSD?". Medical Hypotheses79 (6): 750–753. ISSN1532-2777. PMID22998954. doi:10.1016/j.mehy.2012.08.019.